UNH - Elevance Health: Buy A Dividend Growth Machine
2024-07-18 09:15:00 ET
Summary
- Elevance Health, Inc. has shown remarkable dividend growth in the past decade, exceeding revenue and EPS expectations for the first quarter.
- Elevance's balance sheet remains A-rated, and shares of the stock could be undervalued by 14%.
- The company is positioned to generate over 30% cumulative total returns through 2026, making it a high-quality investment option.
This article was coproduced with Kody Kester.
Elevance Health, Inc. ( ELV ) has been a remarkable dividend grower in the past decade.
The managed care company exceeded expectations for revenue and adjusted diluted EPS for the first quarter.
ELV's balance sheet remains A-rated.
Shares of the stock could be 14% undervalued.
ELV could be positioned to generate 30%+ cumulative total returns through 2026.
Our commitment as income analysts is to highlight the highest-quality stocks in the investment universe. Simply put, if we don't already own a stock or couldn't potentially see a place for it in our portfolio, we're probably not going to cover it....
Elevance Health: Buy A Dividend Growth Machine